Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Cash from Investing Activities

Alexion Pharm Inc Cash from Investing Activities Chart (ALXN)

Alexion Pharm Inc annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Alexion Pharm Inc Cash from Investing Activities for the quarter ending June 06, 2020 was $15m a 158.62% increase of 23m year over year
  • Alexion Pharm Inc Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-704m a 100.80% decrease of -709m year over year
  • Alexion Pharm Inc Annual Cash from Investing Activities for 2019 was $10m a -4,750.52% decrease of -461m from 2018
  • Alexion Pharm Inc Annual Cash from Investing Activities for 2018 was $471m a 295.18% increase of 1,389m from 2017
  • Alexion Pharm Inc Annual Cash from Investing Activities for 2017 was $-918m a 68.68% decrease of -631m from 2016
Other Cash Flow Metrics:
  • Alexion Pharm Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $387m a 33.45% increase of 130m year over year
  • Alexion Pharm Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $227m a 35.57% increase of 81m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Cash from Investing Activities Data

06/2020$15m
03/2020$-766m
12/2019$56m
09/2019$-9m
06/2019$-41m
03/2019$3m
12/2018$52m
09/2018$105m
06/2018$568m
03/2018$-255m

Annual ALXN Cash from Investing Activities Data

2019$10m
2018$471m
2017$-918m
2016$-288m
2015$-3,585m
2014$-223m
2013$-1,027m
2012$-628m
2011$-34m
2010$-89m